Omega-3 Fatty Acids and Cardiovascular Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mozaffarian, 2006, Fish intake, contaminants, and human health: evaluating the risks and the benefits, JAMA, 296, 1885, 10.1001/jama.296.15.1885
Roth, 2010, Fish oil for primary and secondary prevention of coronary heart disease, Curr Atheroscler Rep, 12, 66, 10.1007/s11883-009-0079-6
Kaur, 2011, Docosapentaenoic acid (22:5n-3): a review of its biological effects, Prog Lipid Res, 50, 28, 10.1016/j.plipres.2010.07.004
Sun, 2008, Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction, Am J Clin Nutr, 88, 216, 10.1093/ajcn/88.1.216
Rissanen, 2000, Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study, Circulation, 102, 2677, 10.1161/01.CIR.102.22.2677
Oda, 2005, A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction, Int Heart J, 46, 583, 10.1536/ihj.46.583
Roos, 2007, The role of fish in food-based strategies to combat vitamin A and mineral deficiencies in developing countries, J Nutr, 137, 1106, 10.1093/jn/137.4.1106
Fox, 2004, Bioavailability of selenium from fish, yeast and selenate: a comparative study in humans using stable isotopes, Eur J Clin Nutr, 58, 343, 10.1038/sj.ejcn.1601787
Holden, 2008, Vitamin D in foods: development of the US Department of Agriculture database, Am J Clin Nutr, 87, 1092S, 10.1093/ajcn/87.4.1092S
Burdge, 2004, Alpha-linolenic acid metabolism in men and women: nutritional and biological implications, Curr Opin Clin Nutr Metab Care, 7, 137, 10.1097/00075197-200403000-00006
Burdge, 2003, Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]alpha-linolenic acid to longer-chain fatty acids and partitioning towards beta-oxidation in older men, Br J Nutr, 90, 311, 10.1079/BJN2003901
Burdge, 2002, Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men, Br J Nutr, 88, 355, 10.1079/BJN2002662
Emken, 1994, Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males, Biochim Biophys Acta, 1213, 277, 10.1016/0005-2760(94)00054-9
Pawlosky, 2001, Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans, J Lipid Res, 42, 1257, 10.1016/S0022-2275(20)31576-5
2010
Brouwer, 2004, Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis, J Nutr, 134, 919, 10.1093/jn/134.4.919
Kromhout, 2010, n-3 fatty acids and cardiovascular events after myocardial infarction, N Engl J Med, 363, 2015, 10.1056/NEJMoa1003603
Mente, 2009, A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease, Arch Intern Med, 169, 659, 10.1001/archinternmed.2009.38
Mozaffarian, 2005, Does alpha-linolenic acid intake reduce the risk of coronary heart disease?, Altern Ther Health Med, 11, 24
Wang, 2006, n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review, Am J Clin Nutr, 84, 5, 10.1093/ajcn/84.1.5
2000
1998
Mozaffarian, 2011, Mercury exposure and risk of cardiovascular disease in two U.S. cohorts, N Engl J Med, 364, 1116, 10.1056/NEJMoa1006876
Schecter, 2001, Intake of dioxins and related compounds from food in the U.S. population, J Toxicol Environ Health A, 63, 1, 10.1080/152873901750128326
Foran, 2005, Quantitative analysis of the benefits and risks of consuming farmed and wild salmon, J Nutr, 135, 2639, 10.1093/jn/135.11.2639
Gewin, 2004, Troubled waters: the future of global fisheries, PLoS Biol, 2, E113, 10.1371/journal.pbio.0020113
Pauly, 2005, Global trends in world fisheries: impacts on marine ecosystems and food security, Philos Trans R Soc Lond B Biol Sci, 360, 5, 10.1098/rstb.2004.1574
2005
Harris, 2006, Why do omega-3 fatty acids lower serum triglycerides?, Curr Opin Lipidol, 17, 387, 10.1097/01.mol.0000236363.63840.16
Faeh, 2005, Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men, Diabetes, 54, 1907, 10.2337/diabetes.54.7.1907
Clarke, 2001, Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome, J Nutr, 131, 1129, 10.1093/jn/131.4.1129
Rivellese, 1996, Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia, Diabetes Care, 19, 1207, 10.2337/diacare.19.11.1207
Saraswathi, 2009, Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice, J Nutr, 139, 2380, 10.3945/jn.109.111567
Jump, 2011, Fatty acid regulation of hepatic lipid metabolism, Curr Opin Clin Nutr Metab Care, 14, 115, 10.1097/MCO.0b013e328342991c
Hein, 2010, Nuclear receptors and hepatic lipidogenic enzyme response to a dyslipidemic sucrose-rich diet and its reversal by fish oil n-3 polyunsaturated fatty acids, Am J Physiol Endocrinol Metab, 298, E429, 10.1152/ajpendo.00513.2009
Sato, 2010, Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis, Diabetes, 59, 2495, 10.2337/db09-1554
Tanaka, 2010, Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice, Biochem Pharmacol, 80, 1601, 10.1016/j.bcp.2010.07.031
Wada, 2008, Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice, J Hepatol, 49, 441, 10.1016/j.jhep.2008.04.026
Gonzalez-Periz, 2009, Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins, FASEB J, 23, 1946, 10.1096/fj.08-125674
Nobili, 2011, Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial, Arch Dis Child, 96, 350, 10.1136/adc.2010.192401
Masterton, 2010, Review article: omega-3 fatty acids—a promising novel therapy for non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 31, 679, 10.1111/j.1365-2036.2009.04230.x
Geleijnse, 2002, Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials, J Hypertens, 20, 1493, 10.1097/00004872-200208000-00010
Mozaffarian, 2005, Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials, Circulation, 112, 1945, 10.1161/CIRCULATIONAHA.105.556886
McLennan, 2001, Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models, Lipids, 36, S111, 10.1007/s11745-001-0692-x
Leaf, 2003, Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils, Circulation, 107, 2646, 10.1161/01.CIR.0000069566.78305.33
Billman, 1997, Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs, Lipids, 32, 1161, 10.1007/s11745-997-0149-2
O’Keefe, 2006, Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions, Am J Cardiol, 97, 1127, 10.1016/j.amjcard.2005.11.025
Kenny, 1992, Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men, Am J Cardiol, 70, 1347, 10.1016/0002-9149(92)90773-R
Chin, 1993, Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans, Hypertension, 21, 22, 10.1161/01.HYP.21.1.22
Harris, 1997, n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans, Am J Clin Nutr, 65, 459, 10.1093/ajcn/65.2.459
Stirban, 2010, Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus, Am J Clin Nutr, 91, 808, 10.3945/ajcn.2009.28374
Leeson, 2002, Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood, Eur Heart J, 23, 216, 10.1053/euhj.2001.2728
Dangardt, 2010, Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents, Atherosclerosis, 212, 580, 10.1016/j.atherosclerosis.2010.06.046
Rizza, 2009, Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes, Atherosclerosis, 206, 569, 10.1016/j.atherosclerosis.2009.03.006
Goodfellow, 2000, Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia, J Am Coll Cardiol, 35, 265, 10.1016/S0735-1097(99)00548-3
Mori, 2000, Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men, Circulation, 102, 1264, 10.1161/01.CIR.102.11.1264
Wright, 2008, A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus, Ann Rheum Dis, 67, 841, 10.1136/ard.2007.077156
Nestel, 2002, The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans, Am J Clin Nutr, 76, 326, 10.1093/ajcn/76.2.326
McVeigh, 1994, Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus, Arterioscler Thromb, 14, 1425, 10.1161/01.ATV.14.9.1425
Wang, 2004, Effects of omega-3 fatty acids on cardiovascular disease, Evid Rep Technol Assess (Summ), 1
Balk, 2004, Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease, Evid Rep Technol Assess (Summ), 93, 1
Kristensen, 2001, n-3 polyunsaturated fatty acids and coronary thrombosis, Lipids, 36, S79, 10.1007/s11745-001-0686-8
Reis, 1989, Randomised trial of fish oil for prevention of restenosis after coronary angioplasty, Lancet, 2, 177, 10.1016/S0140-6736(89)90370-X
Eritsland, 1995, Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease, Blood Coagul Fibrinolysis, 6, 17, 10.1097/00001721-199502000-00003
Mozaffarian, 2011, The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) trial—rationale and design, Am Heart J, 162, 56, 10.1016/j.ahj.2011.03.035
Engler, 2004, Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study, Int J Clin Pharmacol Ther, 42, 672, 10.5414/CPP42672
Haberka, 2011, N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction N-3 PUFA supplementation in acute myocardial infarction, Clin Nutr, 30, 79, 10.1016/j.clnu.2010.07.011
Schiano, 2008, Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function, Clin Nutr, 27, 241, 10.1016/j.clnu.2007.11.007
Tagawa, 1999, Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease, J Cardiovasc Pharmacol, 33, 633, 10.1097/00005344-199904000-00017
Doshi, 2001, Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide, Clin Sci (Lond), 101, 629, 10.1042/cs1010629
Okuda, 1997, Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells, Biochem Biophys Res Commun, 232, 487, 10.1006/bbrc.1997.6328
Omura, 2001, Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation, FEBS Lett, 487, 361, 10.1016/S0014-5793(00)02351-6
Singh, 2010, Eicosapentaenoic acid-induced endothelium-dependent and -independent relaxation of sheep pulmonary artery, Eur J Pharmacol, 636, 108, 10.1016/j.ejphar.2010.02.041
Lopez, 2008, Long-chain n-3 polyunsaturated fatty acid from fish oil modulates aortic nitric oxide and tocopherol status in the rat, Br J Nutr, 100, 767, 10.1017/S0007114508939854
Robinson, 2006, Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids, Am J Cardiol, 98, 39i, 10.1016/j.amjcard.2005.12.026
Kris-Etherton, 2002, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Circulation, 106, 2747, 10.1161/01.CIR.0000038493.65177.94
de Roos, 2009, Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease, Br J Pharmacol, 158, 413, 10.1111/j.1476-5381.2009.00189.x
Russo, 1995, Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension, J Hypertens, 13, 1823, 10.1097/00004872-199512010-00059
Christensen, 1996, Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial, BMJ, 312, 677, 10.1136/bmj.312.7032.677
Christensen, 1998, Heart rate variability and n-3 fatty acids in patients with chronic renal failure—a pilot study, Clin Nephrol, 49, 102
Christensen, 1999, Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids, Am J Clin Nutr, 70, 331, 10.1093/ajcn/70.3.331
Park, 2009, Fruit, vegetable, and fish consumption and heart rate variability: the Veterans Administration Normative Aging Study, Am J Clin Nutr, 89, 778, 10.3945/ajcn.2008.26849
Romieu, 2005, Omega-3 fatty acid prevents heart rate variability reductions associated with particulate matter, Am J Respir Crit Care Med, 172, 1534, 10.1164/rccm.200503-372OC
Christensen, 2001, Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography, Circulation, 103, 651, 10.1161/01.CIR.103.5.651
Villa, 2002, Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease, Pharmacol Res, 45, 475, 10.1006/phrs.2002.0989
Geelen, 2003, Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects, Am Heart J, 146, E4, 10.1016/S0002-8703(03)00441-1
Holguin, 2005, Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly, Chest, 127, 1102
Dyerberg, 2004, Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study, Eur J Clin Nutr, 58, 1062, 10.1038/sj.ejcn.1601934
Fiedler, 2005, Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism, J Ren Nutr, 15, 253, 10.1053/j.jrn.2005.01.007
Charnock, 1992, Dietary modulation of lipid metabolism and mechanical performance of the heart, Mol Cell Biochem, 116, 19, 10.1007/BF01270564
Ghio, 2010, Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial, Eur J Heart Fail, 12, 1345, 10.1093/eurjhf/hfq172
Grimsgaard, 1998, Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans, Am J Clin Nutr, 68, 52, 10.1093/ajcn/68.1.52
McLennan, 1992, Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling, Cardiovasc Res, 26, 871, 10.1093/cvr/26.9.871
Mozaffarian, 2006, Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics, Am J Cardiol, 97, 216, 10.1016/j.amjcard.2005.08.025
Peoples, 2008, Fish oil reduces heart rate and oxygen consumption during exercise, J Cardiovasc Pharmacol, 52, 540, 10.1097/FJC.0b013e3181911913
Pepe, 2002, Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function, Circulation, 105, 2303, 10.1161/01.CIR.0000015604.88808.74
Nodari, 2011, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy, J Am Coll Cardiol, 57, 870, 10.1016/j.jacc.2010.11.017
Djousse, 2011, Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes, Am J Clin Nutr, 93, 143, 10.3945/ajcn.110.005603
Kaushik, 2009, Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus, Am J Clin Nutr, 90, 613, 10.3945/ajcn.2008.27424
Brostow, 2011, Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study, Am J Clin Nutr, 94, 520, 10.3945/ajcn.110.009357
Laaksonen, 2002, Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men, Diabet Med, 19, 456, 10.1046/j.1464-5491.2002.00707.x
Villegas, 2011, Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women, Am J Clin Nutr, 94, 543, 10.3945/ajcn.111.013193
Wang, 2003, Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study, Am J Clin Nutr, 78, 91, 10.1093/ajcn/78.1.91
van Dam, 2002, Dietary fat and meat intake in relation to risk of type 2 diabetes in men, Diabetes Care, 25, 417, 10.2337/diacare.25.3.417
Djousse, 2011, Plasma omega-3 fatty acids and incident diabetes in older adults, Am J Clin Nutr, 94, 527, 10.3945/ajcn.111.013334
Friedberg, 1998, Fish oil and glycemic control in diabetes. A meta-analysis, Diabetes Care, 21, 494, 10.2337/diacare.21.4.494
Hartweg, 2008, Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus, Cochrane Database Syst Rev, 10.1002/14651858.CD003205.pub2
Montori, 2000, Fish oil supplementation in type 2 diabetes: a quantitative systematic review, Diabetes Care, 23, 1407, 10.2337/diacare.23.9.1407
Puhakainen, 1995, Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus, Am J Clin Nutr, 61, 121, 10.1093/ajcn/61.1.121
Giacco, 2007, Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?, Nutr Metab Cardiovasc Dis, 17, 572, 10.1016/j.numecd.2006.06.006
Jump, 2008, N-3 polyunsaturated fatty acid regulation of hepatic gene transcription, Curr Opin Lipidol, 19, 242, 10.1097/MOL.0b013e3282ffaf6a
Shearer, 2010, Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters, J Lipid Res, 51, 2074, 10.1194/jlr.M900193-JLR200
Nakamura, 2005, Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer, Nutrition, 21, 639, 10.1016/j.nut.2005.03.001
Mickleborough, 2003, Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes, Am J Respir Crit Care Med, 168, 1181, 10.1164/rccm.200303-373OC
von Schacky, 1993, n-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo, J Lab Clin Med, 121, 302
Accinni, 2006, Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects, Nutr Metab Cardiovasc Dis, 16, 121, 10.1016/j.numecd.2005.05.006
Micallef, 2009, Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals, Atherosclerosis, 204, 476, 10.1016/j.atherosclerosis.2008.09.020
Seierstad, 2005, Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis, Eur J Clin Invest, 35, 52, 10.1111/j.1365-2362.2005.01443.x
Madsen, 2007, C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study, Eur J Nutr, 46, 428, 10.1007/s00394-007-0673-8
Madsen, 2003, The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study, Br J Nutr, 89, 517, 10.1079/BJN2002815
Mori, 2003, Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects, Free Radic Biol Med, 35, 772, 10.1016/S0891-5849(03)00407-6
Yusof, 2008, Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men, Prostaglandins Leukot Essent Fatty Acids, 78, 219, 10.1016/j.plefa.2008.02.002
James, 2010, Fish oil and rheumatoid arthritis: past, present and future, Proc Nutr Soc, 69, 316, 10.1017/S0029665110001564
Goldberg, 2007, A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain, Pain, 129, 210, 10.1016/j.pain.2007.01.020
Serhan, 2010, Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?, Am J Pathol, 177, 1576, 10.2353/ajpath.2010.100322
Dlugosova, 2009, Modulation of connexin-43 by omega-3 fatty acids in the aorta of old spontaneously hypertensive rats, J Physiol Pharmacol, 60, 63
Fischer, 2008, Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension, Hypertension, 51, 540, 10.1161/HYPERTENSIONAHA.107.103143
Radosinska, 2011, Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats, Mol Cell Biochem, 347, 163, 10.1007/s11010-010-0625-0
Zhang, 1999, Pretreatment with eicosapentaenoic acid prevented hypoxia/reoxygenation-induced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity, Prostaglandins Leukot Essent Fatty Acids, 61, 33, 10.1054/plef.1999.0070
Brouwer, 2009, Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators, Eur Heart J, 30, 820, 10.1093/eurheartj/ehp003
Saravanan, 2010, Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial, Circ Arrhythm Electrophysiol, 3, 46, 10.1161/CIRCEP.109.899633
Heidt, 2009, Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study, Thorac Cardiovasc Surg, 57, 276, 10.1055/s-0029-1185301
Calo, 2005, N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial, J Am Coll Cardiol, 45, 1723, 10.1016/j.jacc.2005.02.079
Heidarsdottir, 2010, Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?, Europace, 12, 356, 10.1093/europace/eup429
Kumar, 2011, Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology, Heart Rhythm, 8, 562, 10.1016/j.hrthm.2010.12.017
Farquharson, 2011, Effect of dietary fish oil on atrial fibrillation after cardiac surgery, Am J Cardiol, 108, 851, 10.1016/j.amjcard.2011.04.036
Kim, 2010, Regulatory activity of polyunsaturated fatty acids in T-cell signaling, Prog Lipid Res, 49, 250, 10.1016/j.plipres.2010.01.002
Coskun, 2010, Membrane rafting: from apical sorting to phase segregation, FEBS Lett, 584, 1685, 10.1016/j.febslet.2009.12.043
Dart, 2010, Lipid microdomains and the regulation of ion channel function, J Physiol, 588, 3169, 10.1113/jphysiol.2010.191585
Ma, 2004, n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon, FASEB J, 18, 1040, 10.1096/fj.03-1430fje
Chapkin, 2002, Dietary n-3 PUFA affect TcR-mediated activation of purified murine T cells and accessory cell function in co-cultures, Clin Exp Immunol, 130, 12, 10.1046/j.1365-2249.2002.01951.x
Fan, 2004, Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production, J Immunol, 173, 6151, 10.4049/jimmunol.173.10.6151
Wong, 2009, Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner, J Biol Chem, 284, 27384, 10.1074/jbc.M109.044065
Lee, 2003, Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids, J Lipid Res, 44, 479, 10.1194/jlr.M200361-JLR200
Grossfield, 2006, A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids, Proc Natl Acad Sci U S A, 103, 4888, 10.1073/pnas.0508352103
Gawrisch, 2008, Structure and dynamics of polyunsaturated hydrocarbon chains in lipid bilayers-significance for GPCR function, Chem Phys Lipids, 153, 64, 10.1016/j.chemphyslip.2008.02.016
Xiao, 2006, Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids, Am J Physiol Cell Physiol, 290, C362, 10.1152/ajpcell.00296.2005
Ander, 2007, Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid, Cardiovasc Res, 73, 395, 10.1016/j.cardiores.2006.09.013
Ferrier, 2002, Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes, Cardiovasc Res, 54, 601, 10.1016/S0008-6363(02)00275-4
Li, 2009, Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes, Cardiovasc Res, 81, 286, 10.1093/cvr/cvn322
Xiao, 2001, Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na+ channels, Proc Natl Acad Sci U S A, 98, 3606, 10.1073/pnas.061003798
Xiao, 2004, Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells, Biochem Biophys Res Commun, 321, 116, 10.1016/j.bbrc.2004.06.114
Dujardin, 2008, Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts, Am J Physiol Heart Circ Physiol, 295, H1414, 10.1152/ajpheart.01219.2007
Leifert, 1999, Inhibition of cardiac sodium currents in adult rat myocytes by n-3 polyunsaturated fatty acids, J Physiol, 520, 671, 10.1111/j.1469-7793.1999.00671.x
Den Ruijter, 2007, Pro- and antiarrhythmic properties of a diet rich in fish oil, Cardiovasc Res, 73, 316, 10.1016/j.cardiores.2006.06.014
London, 2007, Circulation, 116, e320
Oh, 2010, GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects, Cell, 142, 687, 10.1016/j.cell.2010.07.041
1999, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial, Lancet, 354, 447, 10.1016/S0140-6736(99)07072-5
Albert, 2002, Blood levels of long-chain n-3 fatty acids and the risk of sudden death, N Engl J Med, 346, 1113, 10.1056/NEJMoa012918
Siscovick, 1995, Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest, JAMA, 274, 1363, 10.1001/jama.1995.03530170043030
Adkins, 2010, Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids, J Nutr Biochem, 21, 781, 10.1016/j.jnutbio.2009.12.004
Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta, Proc Natl Acad Sci U S A, 94, 4312, 10.1073/pnas.94.9.4312
Hertz, 1998, Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha, Nature, 392, 512, 10.1038/33185
Fan, 2003, Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes, Carcinogenesis, 24, 1541, 10.1093/carcin/bgg110
de Urquiza, 2000, Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain, Science, 290, 2140, 10.1126/science.290.5499.2140
Schroeder, 2008, Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription, Lipids, 43, 1, 10.1007/s11745-007-3111-z
Wolfrum, 2001, Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus, Proc Natl Acad Sci U S A, 98, 2323, 10.1073/pnas.051619898
Deckelbaum, 2006, n-3 fatty acids and gene expression, Am J Clin Nutr, 83, 1520S, 10.1093/ajcn/83.6.1520S
Sheena, 2005, Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4alpha, J Lipid Res, 46, 328, 10.1194/jlr.M400371-JLR200
Banga, 2009, Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids, Am J Physiol Endocrinol Metab, 296, E480, 10.1152/ajpendo.90892.2008
Itoh, 2007, Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects, Arterioscler Thromb Vasc Biol, 27, 1918, 10.1161/ATVBAHA.106.136853
Massaro, 2006, The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition, Proc Natl Acad Sci U S A, 103, 15184, 10.1073/pnas.0510086103
Li, 2005, EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism, Kidney Int, 67, 867, 10.1111/j.1523-1755.2005.00151.x
Buczynski, 2009, Thematic Review Series: Proteomics, J Lipid Res, 50, 1015, 10.1194/jlr.R900004-JLR200
Caughey, 1996, The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil, Am J Clin Nutr, 63, 116, 10.1093/ajcn/63.1.116
Kelley, 1999, Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men, Lipids, 34, 317, 10.1007/s11745-999-0369-5
Trebble, 2003, Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation, Am J Clin Nutr, 78, 376, 10.1093/ajcn/78.3.376
Rees, 2006, Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men, Am J Clin Nutr, 83, 331, 10.1093/ajcn/83.2.331
Vedin, 2010, Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study, J Lipid Res, 51, 1179, 10.1194/jlr.M002667
Sperling, 1993, Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils, J Clin Invest, 91, 651, 10.1172/JCI116245
An, 2009, Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney, Am J Physiol Renal Physiol, 297, F895, 10.1152/ajprenal.00217.2009
Spector, 2007, Action of epoxyeicosatrienoic acids on cellular function, Am J Physiol Cell Physiol, 292, C996, 10.1152/ajpcell.00402.2006
Imig, 2009, Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases, Nat Rev Drug Discov, 8, 794, 10.1038/nrd2875
Ferrucci, 2006, Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers, J Clin Endocrinol Metab, 91, 439, 10.1210/jc.2005-1303
Harris, 2007, Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events, Atherosclerosis, 193, 1, 10.1016/j.atherosclerosis.2007.03.018
Arnold, 2010, Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids, Pharmacol Rep, 62, 536, 10.1016/S1734-1140(10)70311-X
Serhan, 2007, Resolution of inflammation: state of the art, definitions and terms, FASEB J, 21, 325, 10.1096/fj.06-7227rev
Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat Rev Immunol, 8, 349, 10.1038/nri2294
Hercule, 2007, The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents, Exp Physiol, 92, 1067, 10.1113/expphysiol.2007.038166
Ye, 2002, Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels, J Pharmacol Exp Ther, 303, 768, 10.1124/jpet.303.2.768
Zhang, 2001, EET homologs potently dilate coronary microvessels and activate BK(Ca) channels, Am J Physiol Heart Circ Physiol, 280, H2430, 10.1152/ajpheart.2001.280.6.H2430
Morin, 2009, Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung, Am J Physiol Lung Cell Mol Physiol, 296, L130, 10.1152/ajplung.90436.2008
Lauterbach, 2002, Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators, Hypertension, 39, 609, 10.1161/hy0202.103293
Lu, 2002, Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study, Mol Pharmacol, 62, 1076, 10.1124/mol.62.5.1076
Wang, 2011, Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity, Cardiovasc Res, 90, 344, 10.1093/cvr/cvq411
Morin, 2010, 17,18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase, Am J Respir Cell Mol Biol, 43, 564, 10.1165/rcmb.2009-0155OC
Arnold, 2010, Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids, J Biol Chem, 285, 32720, 10.1074/jbc.M110.118406
Harris, 2009, Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids, J Nutr, 139, 804S, 10.3945/jn.108.101329
He, 2004, Fish consumption and incidence of stroke: a meta-analysis of cohort studies, Stroke, 35, 1538, 10.1161/01.STR.0000130856.31468.47
He, 2004, Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies, Circulation, 109, 2705, 10.1161/01.CIR.0000132503.19410.6B
Hooper, 2004, Omega 3 fatty acids for prevention and treatment of cardiovascular disease, Cochrane Database Syst Rev, CD003177
Hooper, 2006, Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review, BMJ, 332, 752, 10.1136/bmj.38755.366331.2F
Leon, 2008, Effect of fish oil on arrhythmias and mortality: systematic review, BMJ, 337, a2931, 10.1136/bmj.a2931
Marik, 2009, Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review, Clin Cardiol, 32, 365, 10.1002/clc.20604
Feskens, 1993, Epidemiologic studies on Eskimos and fish intake, Ann N Y Acad Sci, 683, 9, 10.1111/j.1749-6632.1993.tb35688.x
Bang, 1980, The composition of the Eskimo food in north western Greenland, Am J Clin Nutr, 33, 2657, 10.1093/ajcn/33.12.2657
Siscovick, 2003, The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death, Circulation, 107, 2632, 10.1161/01.CIR.0000074779.11379.62
Rauch, 2010, OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction, Circulation, 122, 2152, 10.1161/CIRCULATIONAHA.110.948562
Yokoyama, 2007, Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis, Lancet, 369, 1090, 10.1016/S0140-6736(07)60527-3
Burr, 2003, Lack of benefit of dietary advice to men with angina: results of a controlled trial, Eur J Clin Nutr, 57, 193, 10.1038/sj.ejcn.1601539
Burr, 1989, Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART), Lancet, 2, 757, 10.1016/S0140-6736(89)90828-3
Tavazzi, 2008, Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial, Lancet, 372, 1223, 10.1016/S0140-6736(08)61239-8
Galan, 2010, Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial, BMJ, 341, c6273, 10.1136/bmj.c6273
LaRosa, 1999, Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials, JAMA, 282, 2340, 10.1001/jama.282.24.2340
Tanaka, 2008, Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial, Stroke, 39, 2052, 10.1161/STROKEAHA.107.509455
Jahangiri, 2000, Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids, Mol Cell Biochem, 206, 33, 10.1023/A:1007025007403
Kitamura, 2011, Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model, Am J Physiol Heart Circ Physiol, 300, H1814, 10.1152/ajpheart.00771.2010
Laurent, 2008, Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model, Cardiovasc Res, 77, 89, 10.1093/cvr/cvm024
Sakabe, 2007, Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling, Circulation, 116, 2101, 10.1161/CIRCULATIONAHA.107.704759
Sarrazin, 2007, Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs, J Am Coll Cardiol, 50, 1505, 10.1016/j.jacc.2007.05.046
Lau, 2011, Atrial protective effects of n-3 polyunsaturated fatty acids: a long-term study in ovine chronic heart failure, Heart Rhythm, 8, 575, 10.1016/j.hrthm.2010.12.009
Mozaffarian, 2004, Fish intake and risk of incident atrial fibrillation, Circulation, 110, 368, 10.1161/01.CIR.0000138154.00779.A5
Frost, 2005, n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study, Am J Clin Nutr, 81, 50, 10.1093/ajcn/81.1.50
Brouwer, 2006, Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation, Am Heart J, 151, 857, 10.1016/j.ahj.2005.07.029
Berry, 2010, Dietary fish intake and incident atrial fibrillation (from the Women’s Health Initiative), Am J Cardiol, 105, 844, 10.1016/j.amjcard.2009.11.039
Virtanen, 2009, Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men, Circulation, 120, 2315, 10.1161/CIRCULATIONAHA.109.852657
Kowey, 2010, Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial, JAMA, 304, 2363, 10.1001/jama.2010.1735
Leaf, 2005, Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake, Circulation, 112, 2762, 10.1161/CIRCULATIONAHA.105.549527
Raitt, 2005, Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial, JAMA, 293, 2884, 10.1001/jama.293.23.2884
Brouwer, 2006, Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial, JAMA, 295, 2613, 10.1001/jama.295.22.2613
Jenkins, 2008, Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis, CMAJ, 178, 157, 10.1503/cmaj.070261
Mozaffarian, 2007, Fish, n-3 fatty acids, and cardiovascular haemodynamics, J Cardiovasc Med (Hagerstown), 8, S23, 10.2459/01.JCM.0000289279.95427.e2
Duda, 2009, Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction, Cardiovasc Res, 81, 319, 10.1093/cvr/cvn310
Teng, 2010, The beneficial effect of n-3 polyunsaturated fatty acids on doxorubicin-induced chronic heart failure in rats, J Int Med Res, 38, 940, 10.1177/147323001003800320
Levitan, 2010, Fatty fish, marine omega-3 fatty acids and incidence of heart failure, Eur J Clin Nutr, 64, 587, 10.1038/ejcn.2010.50
Levitan, 2009, Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men, Eur Heart J, 30, 1495, 10.1093/eurheartj/ehp111
Mozaffarian, 2005, Fish intake and risk of incident heart failure, J Am Coll Cardiol, 45, 2015, 10.1016/j.jacc.2005.03.038
Dijkstra, 2009, Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: the Rotterdam Study, Eur J Heart Fail, 11, 922, 10.1093/eurjhf/hfp126
Belin, 2011, Fish intake and the risk of incident heart failure: the Women’s Health Initiative, Circ Heart Fail, 4, 404, 10.1161/CIRCHEARTFAILURE.110.960450
Mozaffarian, 2011, Circulating long-chain omega-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study, Ann Intern Med, 155, 160, 10.7326/0003-4819-155-3-201108020-00006
Tatarczyk, 2007, Analysis of long-chain omega-3 fatty acid content in fish-oil supplements, Wien Klin Wochenschr, 119, 417, 10.1007/s00508-007-0820-5
Abete, 2009, PUFA for human health: diet or supplementation?, Curr Pharm Des, 15, 4186, 10.2174/138161209789909665
2001
2002, The dietary reference intakes for energy, carbohydrates, fiber, fat, protein and amino acids (macronutrients), 45
2003, Diet, Nutrition and the Prevention of Chronic Diseases, 89
Lichtenstein, 2006, Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee, Circulation, 114, 82, 10.1161/CIRCULATIONAHA.106.176158
Simopoulos, 1999, Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids, Ann Nutr Metab, 43, 127, 10.1159/000012777
Van de Werf, 2003, Management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 24, 28, 10.1016/S0195-668X(02)00618-8
Lloyd-Jones, 2010, Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond, Circulation, 121, 586, 10.1161/CIRCULATIONAHA.109.192703
Roger, 2011, Heart disease and stroke statistics—2011 update: a report from the American Heart Association, Circulation, 123, e18, 10.1161/CIR.0b013e3182009701
Harris, 2007, International recommendations for consumption of long-chain omega-3 fatty acids, J Cardiovasc Med (Hagerstown), 8, S50, 10.2459/01.JCM.0000289274.64933.45
Harris, 1997, n-3 fatty acids and serum lipoproteins: human studies, Am J Clin Nutr, 65, 1645S, 10.1093/ajcn/65.5.1645S
Hamazaki, 2003, n-3 long-chain FA decrease serum levels of TG and remnant-like particle-cholesterol in humans, Lipids, 38, 353, 10.1007/s11745-003-1069-x